Bretscher MT, Dahal P, Griffin J, Stepniewska K, Bassat Q, et al.
2020-02-25 • BMC Medicine
2020-02-25 • BMC Medicine
BACKGROUND The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquin...
Boyce RM, Muhindo E, Baguma E, Muhindo R, Shem B, et al.
2022-02-23 • Malaria Journal
2022-02-23 • Malaria Journal
BACKGROUND Progress against malaria has stalled and may even be slipping backwards in high-burden countries. This is due to a range of factors including insecticide resistance and mo...
WorldWide Antimalarial Resistance Network Methodology Study Group, Dahal P, Simpson JA, Abdulla S, Achan J, et al.
2019-07-05 • Malaria Journal
2019-07-05 • Malaria Journal
BACKGROUND Therapeutic efficacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potenti...